Overview

Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
0
Participant gender:
All
Summary
To characterize the burden of disease in GERD patients of prescription therapy'
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AstraZeneca
Treatments:
Esomeprazole
Criteria
Inclusion Criteria:

- Signed informed consent, 18 years or older, diagnosis of GERD

Exclusion Criteria:

- Peptic ulcer disease, upper gastrointestinal surgery, malignancy